Citigroup’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04M Buy
898,421
+287,272
+47% +$1.26M ﹤0.01% 2125
2025
Q4
$2.94M Buy
611,149
+413,311
+209% +$1.86M ﹤0.01% 2401
2025
Q3
$898K Sell
197,838
-31,976
-14% -$117K ﹤0.01% 3221
2025
Q2
$710K Sell
229,814
-32,022
-12% -$106K ﹤0.01% 3398
2025
Q1
$914K Buy
261,836
+74,116
+39% +$247K ﹤0.01% 3311
2024
Q4
$614K Buy
187,720
+78,669
+72% +$289K ﹤0.01% 3686
2024
Q3
$420K Sell
109,051
-1,032,262
-90% -$3.96M ﹤0.01% 3838
2024
Q2
$3.53M Buy
1,141,313
+914,425
+403% +$2.74M ﹤0.01% 1886
2024
Q1
$585K Buy
226,888
+205,603
+966% +$533K ﹤0.01% 3461
2023
Q4
$53.2K Sell
21,285
-117,571
-85% -$230K ﹤0.01% 4486
2023
Q3
$282K Buy
138,856
+61,098
+79% +$128K ﹤0.01% 3452
2023
Q2
$179K Buy
77,758
+75,978
+4,268% +$198K ﹤0.01% 3939
2023
Q1
$5.39K Sell
1,780
-993
-36% -$2.8K ﹤0.01% 4925
2022
Q4
$6.46K Sell
2,773
-654
-19% -$1.56K ﹤0.01% 4976
2022
Q3
$7K Sell
3,427
-6,170
-64% -$14.5K ﹤0.01% 5099
2022
Q2
$26K Buy
9,597
+2,803
+41% +$7.17K ﹤0.01% 4850
2022
Q1
$20K Sell
6,794
-17,860
-72% -$54.7K ﹤0.01% 5136
2021
Q4
$96K Buy
24,654
+9,975
+68% +$38.7K ﹤0.01% 4751
2021
Q3
$63K Buy
14,679
+5,117
+54% +$17.1K ﹤0.01% 4616
2021
Q2
$29K Sell
9,562
-20,828
-69% -$64.5K ﹤0.01% 5097
2021
Q1
$101K Sell
30,390
-24,880
-45% -$96K ﹤0.01% 4356
2020
Q4
$196K Buy
55,270
+46,724
+547% +$164K ﹤0.01% 5006
2020
Q3
$27K Buy
8,546
+5,600
+190% +$17K ﹤0.01% 5969
2020
Q2
$5K Sell
2,946
-100
-3% -$164 ﹤0.01% 7249
2020
Q1
$3K Sell
3,046
-2,714
-47% -$7.34K ﹤0.01% 7352
2019
Q4
$16K Sell
5,760
-2,168
-27% -$3.51K ﹤0.01% 7014
2019
Q3
$12K Sell
7,928
-4,985
-39% -$8.59K ﹤0.01% 6974
2019
Q2
$27K Buy
12,913
+3,127
+32% +$8K ﹤0.01% 6922
2019
Q1
$35K Sell
9,786
-759
-7% -$2.91K ﹤0.01% 6611
2018
Q4
$41K Sell
10,545
-13,579
-56% -$66.9K ﹤0.01% 6390
2018
Q3
$228K Buy
24,124
+14,751
+157% +$146K ﹤0.01% 5124
2018
Q2
$68K Buy
9,373
+5,687
+154% +$33.9K ﹤0.01% 6037
2018
Q1
$18K Buy
3,686
+702
+24% +$3.72K ﹤0.01% 6788
2017
Q4
$15K Sell
2,984
-10,012
-77% -$58.7K ﹤0.01% 6853
2017
Q3
$81K Buy
12,996
+2,000
+18% +$8.55K ﹤0.01% 5716
2017
Q2
$40K Sell
10,996
-2,364
-18% -$8.13K ﹤0.01% 5926
2017
Q1
$44K Sell
13,360
-51,800
-79% -$144K ﹤0.01% 5772
2016
Q4
$160K Buy
65,160
+27,700
+74% +$80.6K ﹤0.01% 5462
2016
Q3
$129K Buy
37,460
+600
+2% +$2.34K ﹤0.01% 5023
2016
Q2
$128K Buy
36,860
+3,959
+12% +$16.8K ﹤0.01% 4875
2016
Q1
$136K Buy
32,901
+19,851
+152% +$70.9K ﹤0.01% 5435
2015
Q4
$58K Sell
13,050
-3,982
-23% -$21.8K ﹤0.01% 5810
2015
Q3
$103K Sell
17,032
-25,150
-60% -$223K ﹤0.01% 4960
2015
Q2
$501K Sell
42,182
-45,770
-52% -$697K ﹤0.01% 3709
2015
Q1
$1.54M Sell
87,952
-1,273
-1% -$26.1K ﹤0.01% 2702
2014
Q4
$1.37M Buy
89,225
+87,743
+5,921% +$1.51M ﹤0.01% 2823
2014
Q3
$31K Sell
1,482
-1,165
-44% -$19K ﹤0.01% 5614
2014
Q2
$35K Buy
2,647
+650
+33% +$9.22K ﹤0.01% 5407
2014
Q1
$44K Buy
1,997
+1,162
+139% +$20.9K ﹤0.01% 5555
2013
Q4
$6K Buy
+835
New +$6.96K ﹤0.01% 6563
2013
Q3
Sell
-20
Closed 6781
2013
Q2
$0 Buy
+20
New +$95 ﹤0.01% 6726

Other funds holding ABUS